HIV-positive people diagnosed with Hodgkin’s lymphoma have excellent health prospects, aidsmap reports. Publishing their findings in Clinical Infectious Diseases, researchers in the French LYMPHOVIR cohort conducted a prospective study including 68 people with HIV who were newly diagnosed with Hodgkin’s lymphoma between 2008 and 2014. They compared the group’s outcomes with a cohort of HIV-negative individuals diagnosed with the cancer at about the same time.

Ninety-four percent of the HIV-positive individuals were taking antiretrovirals (ARVs) at the time of their lymphoma diagnosis. All took ARVs while undergoing cancer treatment.

During a median 38 months of follow-up, five people in the study died: two from early progression of the cancer, one from sepsis, and two after relapse of lymphoma. Two more people relapsed during the follow-up period.

The overall two-year survival rate was 94 percent, while the two-year rate of lack of progression of lymphoma was 89 percent.

The only factor that the researchers found was linked to an increased risk of lymphoma progression or death was age: Members of the cohort who were older than 45 were 8.1 times more likely to experience such an outcome than the younger ones.

To read the aidsmap article, click here.

To read the study abstract, click here.